Enrolling By Invitation PHASE3 INTERVENTIONAL 3-arm
NCT06951087
Intravitreal and Intracameral DEX in NPDR
Effect of Intravitreal and Intracameral Injection of Dexamethasone Sodium Phosphate on Mild to Moderate NPDR During Cataract Phacoemulsification
Sponsor: Affiliated Hospital of Nantong University
Conditions
Non-Proliferative Diabetic Retinopathy
Interventions
Dexamethasone sodium phosphate
Updated 1 time since 2025 Last updated: Apr 22, 2025 Started: Jan 31, 2022 Primary completion: Apr 20, 2025 Completion: Jun 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE3 trial investigates Non-Proliferative Diabetic Retinopathy and is currently ongoing. Affiliated Hospital of Nantong University leads this study, which shows 1 recorded version since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Enrolling By Invitation — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Affiliated Hospital of Nantong University
Data source: Affiliated Hospital of Nantong University
For direct contact, visit the study record on ClinicalTrials.gov .